KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Zimmer Biomet Holdings has reported Asset Writedowns and Impairment over the past 7 years, most recently at $289.8 million for Q4 2022.

  • Quarterly results put Asset Writedowns and Impairment at $289.8 million for Q4 2022, changed N/A from a year ago — trailing twelve months through Dec 2022 was $292.8 million (up 332.94% YoY), and the annual figure for FY2022 was $292.8 million, up 1696.32%.
  • Asset Writedowns and Impairment for Q4 2022 was $289.8 million at Zimmer Biomet Holdings, up from $3.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for ZBH hit a ceiling of $975.9 million in Q4 2018 and a floor of -$142.0 million in Q4 2020.
  • Median Asset Writedowns and Impairment over the past 5 years was $33.0 million (2020), compared with a mean of $206.9 million.
  • Peak annual rise in Asset Writedowns and Impairment hit 258.79% in 2018, while the deepest fall reached 88.38% in 2018.
  • Zimmer Biomet Holdings' Asset Writedowns and Impairment stood at $975.9 million in 2018, then plummeted by 92.82% to $70.1 million in 2019, then crashed by 302.57% to -$142.0 million in 2020, then skyrocketed by 111.48% to $16.3 million in 2021, then soared by 1677.91% to $289.8 million in 2022.
  • The last three reported values for Asset Writedowns and Impairment were $289.8 million (Q4 2022), $3.0 million (Q2 2022), and $16.3 million (Q2 2021) per Business Quant data.